HIPRA, S.A.

Sector: Companies & groupsHQ: SPAIN

EU Lobbying Profiles

HIPRA, S.A.

Declared Spend (Max)

€299,999

Regulatory Meetings

HIPRA, S.A´s introduction of its current activities to the Commission

9/15/2026

Met with Antonella Rossetti (EU)

Exchange of views on EU strategic autonomy for animal health products

4/16/2026

Met with Catherine Geslain-Laneelle (EU)

HIPRA is a biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service

12/10/2025

Met with Anne Fort (EU)

HIPRA presentation

12/8/2025

Met with Joanna Drake (EU)

MCM strategy

12/3/2025

Met with Boriša Falatar (EU)

Introduction of HIPRA

5/14/2025

Met with Olivér Várhelyi (EU)

Introduction of HIPRA

5/14/2025

Met with Katri Teedumäe (EU)

Government Procurement

No government procurement contracts found.

Executive Insider Trades

No executive insider trades reported.